Prostate Diseases Treatment and Symptoms trials Benign Prostatic Hypertrophy; Prostate Disease; Prostate Enlargement; Prostatitis
Prostatitis is any form of inflammation of the prostate gland. Because women do not have a prostate gland, it is a condition only found in men. Prostatitis may account for up to 25 percent of all office visits by young and middle-age men for complaints involving the genital and urinary systems [citation needed]. Signs and symptoms Inflammation of the prostate leads to pain, often during voiding but also in back and rectum. Frequent urination and increased urgency may suggest a ...
Wikipedia - [full article]
Prostate Diseases Clinical Trials
- Diet and PSA Levels in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005960 - Active, not recruiting
stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003084 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00110162 - Recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Atrasentan in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00046943 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00084526 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028574 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer; Hot Flashes
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020995 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
ClinicalTrials.gov Identifier: NCT00003858 - Active, not recruiting
stage III prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer; stage I prostate cancer
- Atrasentan in Treating Patients With Hormone-Naive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00084994 - Recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002602 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- APC8015 and Bevacizumab in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00027599 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who are Undergoing Radiation Therapy
ClinicalTrials.gov Identifier: NCT00020891 - Completed
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005827 - Completed
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Assessing Quality of Life of Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00041301 - Active, not recruiting
Quality of Life; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Brachytherapy in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005939 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054509 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003903 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; Osteoporosis
- Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00077402 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
ClinicalTrials.gov Identifier: NCT00080899 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002723 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00054574 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002511 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003607 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003307 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; radiation toxicity
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
ClinicalTrials.gov Identifier: NCT00005073 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer; Quality of Life
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003517 - Recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Positron Emission Tomography Using Carbon-11 Acetate in Finding Metastasis and Predicting Recurrence in Patients with Newly Diagnosed Prostate Cancer Who Are At Risk for Recurrence After Treatment
ClinicalTrials.gov Identifier: NCT00121212 - Recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Cilengitide in Treating Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00121238 - Recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032006 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005067 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- TG4010 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00040976 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003533 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003534 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00014586 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016107 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00014352 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; Thromboembolism; recurrent prostate cancer
- Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00062309 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
ClinicalTrials.gov Identifier: NCT00004026 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005096 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Docetaxel in Treating Patients With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003781 - Active, not recruiting
Pain; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002775 - Active, not recruiting
adenocarcinoma of the prostate; Quality of Life; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00080678 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00085228 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00052845 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
ClinicalTrials.gov Identifier: NCT00046826 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00022412 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hydrocortisone Plus Aminoglutethimide or Ketoconazole in Treating Patients With Localized Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006371 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003045 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005072 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; recurrent prostate cancer
- Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032058 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003183 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006380 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00003391 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- NCI HIGH PRIORITY CLINICAL TRIAL --- Prostatectomy Compared With Watchful Waiting in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002606 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00071968 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003717 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
- Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00082693 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- PET Scan in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Phase II Study of PSA-3 Peptide Vaccine Emulsified in Montanide ISA-51 in Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030602 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002480 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002703 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage I prostate cancer
- Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00091390 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030277 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
Resources
- About Prostatectomy (For Benign Prostatic Hyperplasia) (American College of Surgeons)
- American Foundation for Urologic Disease